Conflicting data exist regarding the relationship between Chlamydophila pneunoniae (C. pneumoniae) and hypertension. In this study, both C. pneumoniae IgG and IgA titres and Epstein-Barr virus antibody levels were measured in 146 sustained hypertensives defined by 24 h ambulatory blood pressure monitoring (ABPM) and 54 normotensives. C. pneumoniae antibodies were measured by microimmunofluorescence test. IgGX80 and IgAX40 were defined as elevated antibody titres. Epstein-Barr antibodies were measured in order to investigate whether a possible association exists between hypertension and other, similarly widespread in the general population, intracellular microorganisms. All participants underwent casual blood pressure (BP) readings and 24 h ABPM. Subjects having mean 24 h systolic/diastolic ambulatory BP4125/80 mmHg, with or without antihypertensive medication were defined as hypertensives. Controls were free of any history or clinical evidence of hypertension, cardiovascular or pulmonary disease. Of the total participants, 77 hypertensives (52.7%) and 10 normotensives (18.5%) had IgA titres X40 (crosstabs Po0.000), whereas 76 hypertensives (52.1%) and 15 normotensives (27.8%) had IgG titres X80, (crosstabs Po0.002). No difference was found in Epstein-Barr antibodies, between hypertensives and normotensives. In conclusion, C. pneumoniae, but not Epstein-Barr, antibody levels were found significantly higher in sustained hypertensives, suggesting high frequency of chronic C. pneumoniae, infections in this specific group of patients.
Introduction
Chlamydophila pneumoniae is an intracellular Gram negative bacterium that is currently recognized as a significant respiratory pathogen. It can cause acute and chronic pulmonary infections such as pneumonia, bronchitis, sinusitis and pharyngitis in both adults and children. 1 Several studies have documented an association between serologic evidence of C. pneumoniae infection and various forms of vascular disease, such as coronary heart disease, [2] [3] [4] carotid atherosclerotic lesions 5, 6 and ischaemic cerebrovascular disease. 7 However, a number of studies have failed to establish such an association. [8] [9] [10] [11] [12] Similarly, in prior research efforts, conflicting findings exist regarding the relation between C. pneumoniae antibodies and essential hypertension. 13, 14 This discrepancy may be the result of performing different serological methods (enzymelinked immunosorbent assay (ELISA), microimmunofluorescence (MIF); it could be traced in the examination technicalities used to define hypertension in those studies, or in the sampling procedure.
In order to clarify whether there is a real association between C. pneumoniae and essential hypertension, C. pneumoniae IgA and IgG antibody levels were determined in a selected population of sustained hypertensives and in healthy normotensives. As a result of the existing controversy on whether white-coat hypertension is a benign condition or a pathophysiological entity leading to similar complications with sustained hypertension, 15, 16 white-coat hypertensives were excluded from this study, to avoid possible methodological errors. In order to identify correctly sustained hypertensives, all participants underwent 24 h ambulatory blood pressure monitoring (ABPM).
Antibodies against Epstein-Barr virus (EBV IgM, EBV IgG, EB nuclear antigen (EBNA) IgG, EBV EA IgG were also measured to examine whether a possible association between essential sustained hypertension and infections concerns, except for C. pneumoniae, and other intracellular microorganisms. It was chosen among others, based on the fact that, like C. pneumoniae, infections by EBV are frequently observed in the Hellenic population.
Materials and methods
Hypertensives were selected among patients consecutively referred to the Outpatient University Hypertension Center of the Department of Clinical Therapeutics at Alexandra University Hospital of Athens. They were included in the sample if all of the following criteria were met: (a) mean 24 h systolic/diastolic ambulatory BP4125/80 mmHg (in accordance with WHO 1999) 17 and (b) history of hypertension (BP4140/90 mmHg, based on three sphygmomanometer measurements during each examination, repeated in three different examinations in 1 month duration). The former criteria for sustained hypertensives is in compliance with the existing literature, according to which the 24 h ABPM is a highly reproducible procedure, adequate to establish the long-term hypertensive status of an individual.
17,18
Controls were selected among healthy subjects proceeding to the hospital for routine medical check-up, including ECG, chest radiograph, echocardiography and ABPM. In the control subjects, the following criteria were met: (a) no history of hypertension, based on previous and past BP measurements (subjects who reported even once in their life BP values X140/90 mmHg were excluded), (b) no history of antihypertensive therapy, (c) BP measurements by sphygmomanometer at the outpatient unit o140/90 mmHg on the first and second visit (on the next day) and mean 24 h ambulatory BP o125/85 mmHg.
Finally, all participants were enrolled only if they had no evidence (history, physical examination, ECG, chest radiograph, echocardiography) of other coexisting cardiovascular or pulmonary disease; no evidence (history, physical examination, previous laboratory tests provided by the patients) of secondary hypertension (Cushing's, Conn's syndrome, pheochromocytoma, etc) immunodeficiency, hypergammaglobulinaemia, autoimmune disease, diabetes mellitus; normal results of serum urea, creatinine, electrolytes, plasma renin activity at rest and after exercise, urinary excretion of catecholamines; and normal renal imaging studies (radionuclide renogram, intravenous pyelography or ultrasound scan).
Body weight and height were measured as body surface area (BSA). Occupation, residence, education, alcohol abuse, smoking habits, hyperlipidaemia, obesity and diabetes mellitus were recorded in each subject. 'Cigarette-years' were calculated as the number of years as a smoker times the average number of smoked cigarettes. In regards to alcohol consumption, the case and control subjects were classified as abstainers and heavy drinkers (men460 g/day; women440 g/day alcohol intake, with reference to the suggestions of the Italian Alcohol Society 19 ). Blood glucose, cholesterol, triglycerides, HDL, LDL, C-reactive protein were determined.
In all, 14 hypertensives refused to participate. Three hypertensives and one control were excluded because they did not meet the serologic criteria (IgGX512). Eventually, 146 hypertensive patients Fusing antihypertensive medication or notFand 54 normotensive controls were included in the study. All participants gave informed consent before entering the study.
Clinic BP measurements
BP was measured three times using a mercury sphygmomanometer (standard cuff applied around the nondominant arm and systolic and diastolic values identified from the first and fifth phase of Korotkoff sounds). During the measurements, the study participants remained seated with the arm placed at the heart level. The three initial BP values were averaged to obtain a single systolic and diastolic 'clinic' value.
ABPM
All participants underwent 24 h ABPM that was performed using oscillometric Spacelabs 90209 equipment (Spacelabs, Redmond, Washington, USA). The monitoring equipment was applied at the end of the medical visit. The device was set to obtain automatic BP readings at 15-min intervals. The monitoring was always performed on a working day and the subjects were instructed to act and work as usual. Eventually, 80-96 pairs of systolic and diastolic BP values/ patient/24 h values and times were fed into a PC/ Pentium II computer. No subject having fewer than three readings per hour, in any of the 24 h, was included in the study. The accuracy of the ABPM system was tested against mercury sphygmomanometer readings, both before each patient was leaving the hospital and on the following day when he returned.
Definition of white-coat hypertension
It was defined as the combination of raised clinic BP (4140 mmHg systolic and/or 90 mmHg diastolic BP) with average daytime ambulatory BPo135/ 85 mmHg. 20 
Serologic analyses
Venus blood was drawn at the entry for the determination of C. pneumoniae IgG and IgA antibodies. Serum aliquots were kept frozen at À201C, until analysed within a few days. The presence of C. pneumoniae-specific IgG and IgA antibodies in serum was determined by MIF technique. Elementary bodies of C. pneumoniae TW 183 strain were used as antigen (BIOS Gmbh Postfach 1640 D-82166 Grafelfing, Munchen, Germany). In order to determine IgA titres, sera were absorbed with Gullsorb (Gull Laboratories) at a dilution of 1/17 to remove all IgG antibodies. 21 Serum dilutions were incubated for 14-15 h at À41C before being applied to antigen slides containing elementary body preparations of C. pneumoniae. After the procedure was performed, coverslips were mounted with buffered glycerol and slides were examined under a Zeiss UV microscope with a Â40 oil immersion lens and a Â10 ocular lens. Control sera were included in every test run. All sera were screened initially at three dilutions: 1/10, 1/80, 1/160, for IgG, and 1/20, 1/40, 1/160 for IgA antibodies. Thereafter, positive sera were tested at higher dilutions 1/320 and 1/512. IgG titre X80 and IgAX40 have been defined as the criterion of elevated C. pneumoniae antibody levels. The same investigator examined all slides without knowledge of whether the samples belonged to patients or controls. Patients having IgG titres X512 were excluded from the study, as they were considered having acute infection or reinfection.
The ELISA method (Gull Laboratories, Inc.) was used in order to detect EBV IgM, EBV IgG, EBNA IgG and EBV EA IgG antibodies of EBV in human serum. Blood was collected and centrifuged after clotting at 1500 g for 10 min. Serum was separated and stored at À201C. In order to perform the ELISA test, sera were loaded into cups, which were placed in the BIOS LAB unit and processed according to the manufacturer's instructions. Antibody titres were expressed as activity units per millilitre (AcU/ml). The IgM response to viral capsid antigen (VCA) is usually present at the onset of the disease, peaking within 4-6 weeks and become undetectable within 2-3 months from onset of clinical symptoms. IgG response is usually present at the onset of the disease and remains detectable for life. Antibodies to EBNA gradually increase in titre, reaching plateau levels after 3-12 months. They persist for life like IgG antibodies to VCA. Positive results for EBV IgG and EBNA IgG were considered as best indication of past infection with EBV. VCA EBV IgG positive and EBNA IgG, negative cases were further differentiated by determination of EBV EA (Early) IgG. All sera positive for EBV VCA IgM and EBV EA (Early) IgG were excluded, as indication of active EBV infection. 22 The relative sensitivity and specificity of the above serologic tests when compared with the reference tests are as follows: for EBV IgM ELISA test 97. 4 The C. pneumoniae MIF IgG assay sensitivity is 65% (by sera) and the specificity is 96%. The C. pneumoniae MIF IgA assay sensitivity is 72% (by sera) and the specificity is 94%.
Statistical analysis
Data are presented as mean 7 s.d. Analysis was performed using the SPSS/PS+ statistical package (SPSS, Inc, Chicago IL, USA). In an effort to obtain an indication about the appropriate sample size regarding both groups, Chebyshev's inequality was used. Specifically, at the confidence level of 95%, the appropriate sample size for the controls was 20 and 45 subjects for IgA and IgG, respectively, while the appropriate sample size for the group of hypertensives was 85 and 130 subjects for IgA and IgG, respectively. Using the above procedure, it was assumed that 1 s.d. difference between the samples' mean and the population mean would suffice. Crosstabs Pearson w 2 test was used to examine the frequency of C. pneumoniae seropositivity and seronegativity between normotensives and hypertensives, smokers and nonsmokers, males and females. Independent-samples t-test was used to relate C. pneumoniae seropositivity with age, biochemical parameters, ABPM variables and clinic BP values. Multivariable discriminant stepwise analyses was used to estimate the possible influence of risk factors for C. pneumoniae infection and hypertension such as age, obesity, gender, hyperlipidaemia, smoking habit. A P-value o0.05 was considered significant.
Results
Values of clinic BP and ambulatory monitoring derivatives, demographic characteristics and serologic analyses in the two groups examined are listed in Table 1 . The two groups did not differ in socioeconomic status, age, male/female ratio by selection, and in lipid profile, blood glucose level, CRP and smoking habit. Only two hypertensives and one normotensive were heavy drinkers.
Of the total participants, 77 hypertensives (52.7%) and 10 normotensives (18.5%) had IgA titres X40 (Po0.000). Of these, 76 hypertensives (52.1%) and 15 normotensives (27.8%) had IgG titres X80, (Po0.002).
EBV IgM and EBV EA (Early) antibodies were not detected in any of the hypertensive and normotensive subjects examined. No statistically significant differences were found in EBV IgG and EBV EBNA antibody levels between hypertensives and control group.
C. pneumoniae IgG and IgA seropositivity was not associated with age and smoking habit. A statistically significant difference in C. pneumoniae IgG and IgA titres was found between men and women (Po0.015 and Po0.016, respectively).
On multivariable discriminant stepwise analyses, IgA antibodies were in the first level associated with hypertension (F-statistic ¼ 19.725, Po0.000), in the second level with gender (F-statistic ¼ 11.966, Po0.000) and in the third level with age (Fstatistic ¼ 9.459, Po0.000). No significant association was indicated between C. pneumoniae IgA antibodies and smoking habit and obesity. C. pneumoniae IgG antibodies were significantly associated with hypertension in the first level (Fstatistic ¼ 10.148, Po0.002) and gender in the second level (F-statistic ¼ 8.408, Po0.000). No significant relation was indicated between IgG antibodies and smoking habit, age and obesity. In the first level hypertension was related with IgA antibodies (F-statistic ¼ 19.725, Po0.000) and in the second level with obesity (F-statistic ¼ 12.594, Po0.000), but not related to IgG antibodies, gender and age.
Discussion
The characteristics of the two groups examined are listed in Table 1 . Our findings show that hypertensives had significantly higher C. pneumoniae IgG and IgA titres, comparing to normotensives. The association between hypertension and C. pneumoniae antibodies remained after the use of multivariable analyses, and we focused on an interesting finding that hypertension was most strongly associated with C. pneumoniae IgA antibodies. We have not examined the chlamydial IgA and IgG antibody titres in different levels of hypertension, so this study cannot provide further information on whether there is a connection between the severity of hypertension and the serological C. pneumoniae antibody levels. It should be noted that the study group consisted of patients who had hypertension (therefore some degree of cardiovascular disease in its broader sense) and the controls who had no such history. As a result, it could be argued that a bias towards cardiovascular disease exists. However, hypertensive subjects in our study had mild hypertension and were selected based on the absence of evidence of end organ disease. Consequently, the possibility of vascular damage in this group was minimized.
C. pneumoniae IgG and IgA seropositivity was not associated with age and smoking habit. A statistically significant difference in C. pneumoniae IgG and IgA titres was found between men and women, in agreement with other reports. 23 No association was demonstrated regarding Epstein-Barr infection and subjects with essential hypertension. No significant difference existed between normotensives and hypertensives in age, gender and smoking, risk factors for the prevalence of C. pneumoniae infection. We further observed that between the two groups examined, body mass index is higher in the group of hypertensives than in normotensives. However, this difference could not have possibly affected our results. Furthermore, there is no strong evidence in the literature up to now connecting the prevalence of C. pneumoniae infection with the body mass index.
We used the MIF test to define antibody titres. Although it is the most currently used method for the serologic diagnosis of C. pneumoniae infection, 
it is bedeviled by a high level of operator error, 24 and by cross-reactions with other chlamydophilae 25 and mycoplasma species. 26, 27 In addition, some investigators support that the detection of C. pneumoniae antibodies may be a poor guide to the presence of infection. 28 As a consequence of the above limitations, it is generally accepted that, for C. pneumoniae, serology is a seriously flawed tool, since it cannot provide high precision. Additionally, the lack of the performance standardizations and the variety of the cutoff titres have made the comparison of data from different laboratories quite difficult. We considered as positive, a higher threshold (X40) than other studies (X8 and X16), 29, 4, 30 in order to minimize the percentage of false-positive results. IgG antibody titres X512 were excluded from our study, as evidence of acute C. pneumoniae infection or reinfection. Certainly, an acute infection cannot be associated with hypertension because of its short-lived effect on the human organism.
PJ Cook et al (1997) 13 have reported an association between C. pneumoniae IgG antibody titres and severe essential hypertension. IgG antibodies were measured to define three groups 'acute', 'previous' or 'no chlamydial infection'. Our results are in agreement with the above findings. However, in this study, C. pneumoniae IgA antibodies were not examined. There is considerable evidence that, of all C. pneumoniae antibodies, the presence of IgA may be the best marker of chronic C. pneumoniae infection. 31, 32 Circulating IgA immunoglobulin is short-lived (half-life 5.8 days); hence, its presence implies that the antigen is still present, and the infection is chronic and persistent. Chronic chlamydial infection could be a contributing factor in the development of hypertension, by triggering a chronic inflammatory process.
Nishimura and co-workers 9 found suggestive evidence of an inverse association between C. pneumoniae and high BP in Japanese adults. Specifically, C. pneumoniae antibodies were determined by a different method, the ELISA and clinic measurementsFbut not 24 h ambulatory BP measurementsFwere provided. Based on the above findings, our research team assumes that the inverse association could be explained by the genetic differences of the Japanese population (different Ethnic origin). 33 Similarly, a number of studies suggest that Japanese people have a higher incidence of variant angina and induced coronary artery spasms after myocardial infarction than Caucasian patients, because of important racial differences. 34 Of course, the previous claims require further investigation. In our study, the sampling population had no ethnic variation. In extension, the classification of normotensives and hypertensives by the sphygmomanometric technique, used in Nishimura's study, does not allow the identification of subjects with sustained hypertension and subjects with white-coat hypertension. 35 To avoid the inclusion of patients with white-coat hypertension that might affect our results, we conducted this study, using, in addition to the clinic BP measurements, 24 h ABPM.
No association between Epstein-Barr infection and hypertension was demonstrated by our findings. EBV is an intracellular agent, which, in the past, has been investigated for implications in atherosclerosis, [36] [37] [38] and it is also widespread in the Hellenic community. Although C. pneumoniae organism is classified as a bacteria, it shares many similarities with viruses, as it is an obligate intracellular organism that diverts the host cell's energy production mechanisms and lyses the host cell at the end of the replication cycle. 39 If EBVelevated antibody levels were more frequently found in hypertensives, it would have led us to the speculation that, in general, they are more susceptible to infections. Thus, the presence of infections in general, suggesting a low immunoresistance, may be an important risk factor that leads to a chronic form of C. pneumoniae infection, 40 and as a result, the association between chronic C. pneumoniae infection and hypertension would have been less clear.
The mechanisms underlying this positive association between C. pneumoniae infection and essential hypertension are not clarified. C. pneumoniae could either be an innocent bystander in atheromatous plaques resulting from high BP, or play a pathogenic role in the progression of established plaques. Nevertheless, it is possible that C. pneumoniae does contribute to the pathogenesis and if so, it could be through a large number of potential mechanisms. Arterial baroreflex control of the BP, located in specific regions of the arterial wall, is stimulated by vessel distensibility resulting from spontaneous arterial pressure changes. It has been demonstrated that atherosclerotic alteration in the architecture of the vessel wall, where baroreceptive endings terminate, is considered the predominant mechanism responsible for the degreased baroreflex sensitivity, leading eventually to hypertension. [41] [42] [43] [44] Accepting the theory that C. pneumoniae contributes to the pathogenesis of atherosclerosis, the settlement of this microorganism in these vessel areas, by inducing a chronic immune response orchestrated by cytokines, activation of monocytes and changes in lipid profile, contributes to structural injury of intima and media. Consequently, the findings of the present study provide suggestive evidence that C. pneumoniae contributes as a risk factorFcombined with otherFto the genesis of hypertension.
Nevertheless, the specific underlying pathophysiological mechanisms that link C. pneumoniae with essential hypertension have not yet been defined. Therefore, further research, in this field, is required to reinforce the evidence presented in this study.
